Indication
Active
1 clinical trial
1 product
Clinical trial
Multicentre Clinical Trial of the Efficacy and Safety of Tislelizumab in Combination With BCG Bladder Instillation in the Prevention of Postoperative Recurrence in Intermediate and High-risk Non-muscle Invasive Bladder CancerStatus: Recruiting, Estimated PCD: 2025-06-01
Product
Tislelizumab